Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

It does make me laugh that somebody posts something on this board about a conversation that they had and everyone takes it as gospel.

I can tell you now that when I spoke with Ken and in my emails with him, he will not talk about AXAL and what is going to happen, he indicates he can’t. And some believe that Ranya would state that AXAL could be scrapped and another smaller trial started, myself I don’t buy that for one minute.

For a start Hov May or can correct me on this, but I don’t believe that Keytruda is used or in trials as a preventative drug for Cervical let alone other indications. AIM2CERV trial is being used to prevent reoccurrence so much earlier in the disease cycle, thus creating a much larger patient population.

Secondly Keytruda is expensive, and the need for a cheaper option provides a huge market both in developed and developing countries.